Canmab 150 Mg Injection

About Canmab 150 Mg Injection

Canmab 150 mg Injection is a targeted therapy medication used in the treatment of certain types of breast cancer and gastric cancer. It contains Trastuzumab as its active ingredient, a monoclonal antibody that specifically targets the HER2 (human epidermal growth factor receptor 2) protein, which promotes the growth of cancer cells. By binding to HER2 receptors, Canmab helps slow down or stop the proliferation of cancer cells and supports the bodys immune system in destroying them.

This injection is administered intravenously under the supervision of a qualified healthcare professional. It is commonly prescribed for patients with HER2-positive cancers, either alone or in combination with other chemotherapy agents.

Key Features:

• Contains Trastuzumab 150 mg
• Used in HER2-positive breast and gastric cancer treatment
• Targeted therapy with high specificity
• Helps inhibit cancer cell growth and spread
• Administered under medical supervision

Packaging: Vial
Dosage Form: Injection
Strength: 150 mg
Route of Administration: Intravenous

Applications:

• Breast cancer treatment (HER2-positive)
• Metastatic gastric cancer

Storage Instructions:

• Store in a refrigerator (2C to 8C)
• Do not freeze
• Protect from light

Safety Information:

• To be used only under medical supervision
• Not recommended during pregnancy unless prescribed
• Regular monitoring is required during treatment